ZENTALIS PHARMACEUTICALS INC (ZNTL) Institutional Ownership Changes & 13F Activity

ZENTALIS PHARMACEUTICALS INC (ZNTL). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings. This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Renaissance Technologies LLC and Viking Global Investors.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2026Renaissance Technologies LLCSell-945,6001,938,145$4,535,259
Q4 2025Renaissance Technologies LLCBuy558,3902,883,745$3,893,056
Q3 2025Renaissance Technologies LLCBuy795,8022,325,355$3,511,286
Q2 2025Renaissance Technologies LLCBuy703,5121,529,553$1,774,281
Q1 2025Renaissance Technologies LLCBuy286,696826,041$1,313,405
Q4 2024Renaissance Technologies LLCSell-17,599539,345$1,634,215
Q3 2024Renaissance Technologies LLCSell-104,738556,944$2,049,554
Q2 2024Renaissance Technologies LLCBuy399,745661,682$2,706,279
Q1 2024Renaissance Technologies LLCSell-47,340261,937$4,128
Q4 2023Renaissance Technologies LLCBuy23,840309,277$4,686
Q3 2023Renaissance Technologies LLCBuy75,000285,437$5,726
Q2 2023Renaissance Technologies LLCBuy177,700210,437$5,936
Q1 2023Renaissance Technologies LLCSell-76,60032,737$563
Q1 2022Viking Global InvestorsSell-91,6282,026,656$93,510
Q1 2022Renaissance Technologies LLCBuy78,000109,337$5,045
Q3 2021Viking Global InvestorsSell-281,0002,118,284$141,162
Q3 2021Renaissance Technologies LLCBuy24,94031,337$2,088
Q1 2021Viking Global InvestorsSell-612,0002,399,284$104,105
Q4 2020Viking Global InvestorsSell-1,432,0003,011,284$156,406
Q4 2020Renaissance Technologies LLCBuy6,3976,397$332
Q2 2020Viking Global InvestorsBuy4,443,2844,443,284$213,366

Frequently asked questions about ZNTL activity

  • Which institutional owners are buying ZNTL?

    Institutional owners buying ZNTL include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in ZNTL activity?

    "Buy" means an investor increased their reported position in ZNTL compared to the prior reporting period. This reflects growing exposure to ZENTALIS PHARMACEUTICALS INC (ZNTL) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in ZNTL increasing?

    Institutional interest in ZNTL can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related ZNTL Institutional Insights